NIH prepares to unveil its position on pricing

WASHINGTON - NIH Director Bernadine Healy this week is scheduled to describe the agency's "current thinking" on whether it should play a role in imposing federal price restraints on drugs that are co-developed with private companies.

Healy will make the presentation on Wednesday at a hearing of the Senate Committee on Aging, said John Coster, staff

Read the full 556 word article

How to gain access

Continue reading with a
two-week free trial.